National Research Corporation (NASDAQ:NRC – Get Free Report) declared a quarterly dividend on Wednesday, July 15th. Investors of record on Friday, September 25th will be paid a dividend of 0.16 per share on Friday, October 9th. This represents a c) dividend on an annualized basis and a yield of 2.9%. The ex-dividend date of this dividend is Friday, September 25th.
National Research has increased its dividend payment by an average of 0.2%annually over the last three years.
National Research Price Performance
NASDAQ:NRC opened at $21.86 on Wednesday. The company has a debt-to-equity ratio of 13.13, a current ratio of 0.65 and a quick ratio of 0.65. National Research has a one year low of $11.01 and a one year high of $23.68. The company has a fifty day moving average price of $21.13 and a 200 day moving average price of $19.47. The stock has a market cap of $497.31 million, a P/E ratio of 87.44 and a beta of 0.35.
Institutional Trading of National Research
Large investors have recently added to or reduced their stakes in the company. Heartland Advisors Inc. raised its stake in shares of National Research by 374.3% in the first quarter. Heartland Advisors Inc. now owns 237,147 shares of the company’s stock valued at $4,027,000 after acquiring an additional 187,147 shares during the last quarter. Fifth Third Bancorp acquired a new position in shares of National Research in the 1st quarter worth approximately $1,531,000. Quantinno Capital Management LP grew its position in National Research by 61.3% during the 1st quarter. Quantinno Capital Management LP now owns 62,329 shares of the company’s stock worth $1,058,000 after acquiring an additional 23,682 shares during the last quarter. Bank of New York Mellon Corp grew its position in National Research by 4.0% during the 1st quarter. Bank of New York Mellon Corp now owns 250,707 shares of the company’s stock worth $4,257,000 after acquiring an additional 9,730 shares during the last quarter. Finally, Empirical Finance LLC acquired a new stake in National Research during the 2nd quarter valued at $431,000. 47.26% of the stock is owned by institutional investors.
About National Research
National Research Corporation, doing business as NRC Health, provides research, analytics and technology solutions to the health care industry. The company helps hospitals, health systems and other care organizations understand patient and consumer perceptions, improve the care experience and strengthen relationships with the communities they serve.
Its offerings include patient and employee experience measurement, market and consumer insights, reputation management, customer relationship tools and analytics designed to support service improvement and strategic decision-making.
Further Reading
- Five stocks we like better than National Research
- Old Dogs, New Tech: 3 Legacy Stocks Powering the AI Boom
- 3 Tech Stocks Positioned for More Upside if the Sector’s Breakout Holds
- AutoZone Shifts Gears, On Track to Reverse Course and Price Recovery
- Meta’s Muse Highlights Arm’s Growing Role in AI Infrastructure
Receive News & Ratings for National Research Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research and related companies with MarketBeat.com's FREE daily email newsletter.
